The authors reply

New England Journal of Medicine

Volumn 369, Issue 17, 2013, Pages 1662-1663

  Griffin, Marie R ^a   Grijalva, Carlos G ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

BACTERIAL COLONIZATION; HOSPITALIZATION; HUMAN; INFECTION RATE; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NASOPHARYNX; PLEURA EMPYEMA; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STAPHYLOCOCCUS INFECTION; VACCINATION;

EID: 84886247298     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1310477     Document Type: Letter

References (5)

1. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008;197:1226-34.
2. Lessa FC, Edwards JR, Fridkin SK, Tenover FC, Horan TC, Gorwitz RJ. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004. Pediatr Infect Dis J 2009;28:577-81.
3. Mera RM, Suaya JA, Amrine-Madsen H, et al. Increasing role of Staphylococcus aureus and community-acquired methicillinresistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist 2011;17:321-8.
4. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011;66:663-8.
5. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002;34:434-40.